News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SBIR Awarded $2.1 Million Maas BiolAB, LLC for Cyclosporin ALS Treatment


10/11/2007 9:22:33 AM

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Maas BiolAB received a Small Business Innovation Research (SBIR) grant of $2.1 million over three years from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) for the translational project “Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS).”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES